Spyre Therapeutics在开创性2期Skyway篮式试验中为首位患者给药,Spy072成为首个在风湿性疾病中研究的抗Tl1a抗体

美股速递
Sep 15

Spyre Therapeutics在开创性2期Skyway篮式试验中为首位患者给药,Spy072成为首个在风湿性疾病中研究的抗Tl1a抗体

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10